UBS Group’s Oak Street Health, Inc. OSH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-478,200
Closed -$18.5M 10353
2023
Q1
$18.5M Buy
478,200
+413,724
+642% +$13.4M 0.01% 1458
2022
Q4
$1.39M Buy
64,476
+42,465
+193% +$888K ﹤0.01% 3760
2022
Q3
$540K Sell
22,011
-121,311
-85% -$3.21M ﹤0.01% 4272
2022
Q2
$2.36M Sell
143,322
-65,936
-32% -$1.28M ﹤0.01% 3012
2022
Q1
$5.62M Buy
209,258
+183,604
+716% +$3.87M ﹤0.01% 2425
2021
Q4
$850K Sell
25,654
-248,323
-91% -$9.4M ﹤0.01% 4534
2021
Q3
$11.7M Buy
273,977
+81,179
+42% +$4.36M ﹤0.01% 1915
2021
Q2
$11.3M Buy
192,798
+165,176
+598% +$9.83M ﹤0.01% 1930
2021
Q1
$1.5M Buy
27,622
+6,028
+28% +$335K ﹤0.01% 3850
2020
Q4
$1.32M Buy
21,594
+2,741
+15% +$144K ﹤0.01% 3784
2020
Q3
$1.01M Buy
+18,853
New +$844K ﹤0.01% 3632

Other funds holding OSH

UBS Group's OSH Position: Q2 2023 in Review

UBS Group sold out of Oak Street Health, Inc. (OSH) in Q2 2023, closing a stake of 478,200 shares — an estimated $18.5M sold.

UBS Group first reported a position in OSH in Q3 2020 and held it in 11 quarters. The position peaked at $18.5M in Q1 2023. 3 funds tracked by Wall St. Rank hold OSH as of Q2 2023.

  • UBS Group reported no remaining Oak Street Health, Inc. position as of Q2 2023 after selling out during the quarter.
  • UBS Group sold 478,200 Oak Street Health, Inc. shares in Q2 2023, an estimated $18.5M.
  • UBS Group first reported a position in Oak Street Health, Inc. in Q3 2020 and held it in 11 quarters.
  • UBS Group's Oak Street Health, Inc. position peaked at $18.5M in Q1 2023.
  • 3 funds tracked by Wall St. Rank held Oak Street Health, Inc. as of Q2 2023.

Based on UBS Group's 13F filing for Q2 2023, filed 11 Aug 2023.